What Is the 7-Point Checklist? 

The 7-point checklist is a 7-point checklist dermoscopy scoring algorithm used to evaluate pigmented skin lesions for features associated with melanoma. It was developed and published in 1998 by Giuseppe Argenziano and his colleagues at the Federico II University of Naples, Italy. 

The Argenziano 7-point checklist was created with a clear goal: to simplify melanoma diagnosis. Earlier methods required clinicians to recognise dozens of subtle dermoscopic patterns.

By reducing the assessment to just seven well-defined features, the checklist made dermoscopy accessible to General Practitioners and trainees, not only specialist dermatologists.

In Argenziano’s original validation study of 342 lesions, the checklist achieved a sensitivity of 95% and a specificity of 75% for melanoma detection. 

The 7 Dermoscopic Criteria 

The seven features fall into two groups based on how strongly each predicts melanoma. Together they capture the most reliable dermoscopic features of melanoma and form the basis of the major and minor criteria of the melanoma scoring system. 

Major Criteria  

1. Atypical pigment network: Irregular meshes with thickened lines, abrupt cut-offs, or uneven distribution. 

2. Blue-white veil: Irregular, confluent blue-white pigmentation overlying part of the lesion. 

3. Atypical vascular pattern: linear-irregular, dotted, or polymorphous blood vessels not seen in benign nevi. 

Minor Criteria  

4. Irregular streaks: Radial pigmented projections at the periphery of the lesion. 

5. Irregular pigmentation: Areas of black, brown, or grey distributed asymmetrically. 

6. Irregular dots and globules: Varying in size, shape and distribution. 

7. Regression structures: White scar-like areas or grey “peppering,” suggesting partial immune destruction of the lesion. 

How to Score and Interpret the Result 

Calculating a 7-point checklist score is straightforward: add 2 points for each major criterion present and 1 point for each minor criterion. A total score of 3 or more should prompt biopsy or excision for histological evaluation. 

This means melanoma can be flagged in several ways: one major plus one minor (2 + 1 = 3), three minor criteria (1 + 1 + 1 = 3), or any larger combination.

A lesion with no positive criteria scores 0 and is most likely benign, while a lesion with multiple major features can easily reach 5 or 6 and demands urgent attention. 

Original vs. Revised 7-Point Checklist 

In 2011, Argenziano and colleagues published the revised 7-point checklist to address limitations of the original in real-world clinical settings. The revised version assigns just 1 point to every criterion — no separate weighting for major and minor features — while keeping the same threshold of ≥ 3 for excision. 

The simplified version reports sensitivity of 85–93% with slightly lower specificity (45–48%). It is easier for non-experts to remember and tends to err on the side of caution, referring more lesions for biopsy but missing fewer melanomas. Many primary-care guidelines now recommend the revised version for this reason. 

Clinical Application and Limitations 

The checklist works well for the majority of pigmented melanocytic lesions on the trunk and limbs. It is less reliable for: 

• Featureless or amelanotic melanomas, which can score 0–2 despite being malignant 

• Facial lesions, where dermoscopic patterns differ 

• Acral lesions on palms, soles and nails 

• Mucosal melanomas 

For these challenging cases, a low score should never be taken as reassurance on its own. Recent research on featureless melanoma has identified additional dermoscopic patterns that can flag lesions the original checklist would miss. 

Accurate scoring also depends heavily on the quality of the dermatoscope used. Polarised light reveals vascular structures and the blue-white veil more clearly than non-polarised light, and good colour rendering is essential for distinguishing regression from benign hypopigmentation. A practical primer on using a dermatoscope is a useful starting point for clinicians new to dermoscopy. 

Why Early Detection Matters 

Melanoma incidence is rising worldwide, with Australia and New Zealand bearing the highest burden. Recent projections of global melanoma trends suggest more than half a million new cases per year by 2040 if current patterns continue. In this context, even modest improvements in primary-care diagnostic accuracy translate into many lives saved. 

Tools like the 7-point checklist, combined with digital dermoscopy and total-body photography, give clinicians a structured, defensible approach to skin checks. Imaging systems that support storage, comparison and follow-up — such as those used for detecting skin cancer with MoleMax — extend the value of the checklist beyond a single appointment, allowing borderline lesions to be monitored over time rather than excised unnecessarily. 

Conclusion 

The 7-point checklist remains one of the most useful and accessible algorithms in dermoscopy. Its strength lies in its simplicity: seven well-defined criteria, a clear scoring system, and a low threshold for action.

For skin cancer clinicians at the front line of detection, mastering the checklist is one of the highest-yield investments of training time available. 

That said, no algorithm is a substitute for clinical judgement, good equipment and the willingness to biopsy when something simply does not look right. Used alongside high-quality dermatoscopes and digital follow-up, the 7-point checklist helps turn a suspicious mole into a defensible decision — and an early-stage melanoma into a curable one. 

The post 7-Point Checklist for Melanoma: A Complete Dermoscopy Guide  appeared first on MoleMax Systems.